Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C in 1994

G Gitnick1

  • 1Division of Digestive Diseases, UCLA School of Medicine 90024-7018, USA.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Hepatitis C, a liver disease discovered in 1989, is often asymptomatic. While interferon therapy can induce remission in 40-50% of patients, relapses are frequent, and effective long-term treatments remain elusive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alginate microbead release assay of angiogenesis.

Methods in molecular medicine·2011
Same author

Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing.

Artificial organs·2001
Same author

Hepatitis C screening strategies in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Automated RIBA HCV strip immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients.

American journal of nephrology·2001
Same author

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

Hepatology (Baltimore, Md.)·2001
Same author

Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same journal

Abstract from the 41st Nordic Gastroenterology Congress, 8-11 June 2010, Copenhagen, Denmark.

Scandinavian journal of gastroenterology. Supplement·2010
Same journal

Abstracts from the XL Nordic Meeting of Gastroenterology, June 8-11, 2009, Stavanger, Norway.

Scandinavian journal of gastroenterology. Supplement·2009
Same journal

Abstracts of the 39th Nordic Meeting of Gastroenterology, 30th Nordic Meeting of Digestive Endoscopy, 18th Nordic Meeting of Gastrointestinal Motility, and the Annual Endoscopy/Gastroenterology Nurses'/Assistants' Meeting Post-graduate course, 4-6 June 2008, Helsinki, Finland.

Scandinavian journal of gastroenterology. Supplement·2008
Same journal

Abstracts from the XXXVIII Nordic Meeting of Gastroenterology, XXIX Nordic Meeting of Digestive Endoscopy, XVII Nordic Meeting of Gastrointestinal Motility, 6-9 June 2007, Reykjavik, Iceland.

Scandinavian journal of gastroenterology. Supplement·2007
Same journal

Abstracts of the XXXVII Nordic Meeting of Gastroenterology, 3-5 May 2006, Vasteras, Sweden.

Scandinavian journal of gastroenterology. Supplement·2006
Same journal

Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.

Scandinavian journal of gastroenterology. Supplement·2006
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection, identified in 1989, is a significant cause of acute and chronic liver disease.
  • The virus typically presents with a long, asymptomatic incubation period.
  • Understanding HCV's pathogenesis is crucial for developing effective interventions.

Purpose of the Study:

  • To evaluate the role of Hepatitis C in liver disease development.
  • To assess the efficacy of interferon therapy in chronically infected patients.
  • To review the long-term treatment outcomes for Hepatitis C.

Main Methods:

  • Literature review of studies on Hepatitis C discovery and its clinical impact.
  • Analysis of data regarding Hepatitis C incubation periods and disease progression.

Related Experiment Videos

  • Evaluation of treatment outcomes, including remission and relapse rates, for interferon therapy.

    • Main Results:

    • Hepatitis C has a mean incubation period of 6-8 weeks and is often indolent.
    • Interferon therapy achieved remission in 40-50% of chronically infected patients after 6 months.
    • High relapse rates, up to 80% within 6 months, were observed post-treatment.

    Conclusions:

    • Hepatitis C poses a significant challenge in liver disease management.
    • Current interferon treatment offers short-term remission but lacks long-term efficacy due to frequent relapses.
    • Further research is needed to establish effective, sustainable long-term treatments for Hepatitis C.